24h-response to bevacizumab erlortinib in non-small cell lung cancer from blood-based exon array profiling

GSE61676

Homo sapiens

86 Downloadable Samples

Affymetrix Human Human Exon 1.0 ST Array (huex10st)

Submitter Supplied Information

Description

The mechanisms of action of the combined targeted therapy bevacizumab erlotinib in late stage non-squamous non-small cell lung cancer was investigated by means of whole genome exon arrays.

PubMed ID

28359318

Publication Title

24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling.

Total Samples

Submitter’s Institution

Cantonal Hospital St. Gallen

Authors

Baty F, Joerger M, Früh M, Klingbiel D, Zappa F, Brutsche M

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-61676

No rows found